Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The clinical behaviour and outcome of young patients with gastroesophageal tumours (GET) is surmised to differ from older patients, yet data on the comparison of these two patient subgroups is scarce. This study focuses on the investigation of the clinical characteristics and survival outcome of younger-age people with GET, when compared to older patients. METHODS: Patients diagnosed with GET at the Medical University of Vienna between 2004 and 2016 were included in this study. Clinical parameters and the overall survival (OS) were compared between young (≤ 45 years) and elderly (≥ 65 years) patients. RESULTS: Among 796 patients, who were eligible for this analysis, fifty-eight patients (7%) were ≤ 45 years at the initial onset of the disease. These 58 young patients were then matched to elderly patients based on the gender, tumour stage, histology and tumour location. The number of metastatic lesions was significantly higher among young patients (p < 0.05). In a non-metastatic setting younger patients showed a significant longer OS than older patients (median 1226 versus 801 days, p = 0.028). Furthermore, young patients with extensive metastatic disease (2 or more metastatic site) had a significantly poorer OS than elderly patients (median 450 versus 646 days, p = 0.033). CONCLUSION: These results indicate that young patients might be diagnosed very late, which might lead to the development of a more aggressive disease compared to older patients, but a relatively long OS when diagnosed and treated in a non-metastatic setting. Thus, screening methods for younger patients might be considerable to enhance the outcome of young patients with GET.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“while young (%45 years old) patients with localized upper gastrointestinal carcinoma experience an extended OS compared with their old (R65 years old) counterparts, the opposite appears to be true for patients with distant disease and at least two metastatic lesions. 268”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [268]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Van Cutsem, E., Sagaert, X., Topal, B., Haustermans, K., & Prenen, H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30354-3 · Cited by 1,793
(2011) · Hepatogastroenterology · doi:10.5754/hge11589 · Cited by 1,756
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Smyth, E. C., Verheij, M., Allum, W., Cunningham, D., Cervantes, A., & Arnold, D. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw350 · Cited by 1,555
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Okines, A., Verheij, M., Allum, W., Cunningham, D., & Cervantes, A. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq164 · Cited by 1,300
Assessment of a HER2 scoring system for gastric cancer: results from a validation study
Hofmann, M., Stoss, O., Shi, D., Büttner, R., Van De Vijver, M., Kim, W., Ochiai, A., Rüschoff, J., & Henkel, T. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03028.x · Cited by 1,187
Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults
Anderson, W. F. (2010) · JAMA · doi:10.1001/jama.2010.496 · Cited by 460
Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity.
Yang, D., Hendifar, A. E., Lenz, C., Togawa, K., Lenz, F., Lurje, G., Pohl, A., Winder, T. L., Ning, Y., Groshen, S. G., et al. (2011) · PubMed · doi:10.3978/j.issn.2078-6891.2010.025 · Cited by 210
Clinicopathological features of gastric cancer in young patients
Takatsu, Y., Hiki, N., Nunobe, S., Ohashi, M., Honda, M., Yamaguchi, T., Nakajima, T., & Sano, T. (2016) · Gastric Cancer · doi:10.1007/s10120-015-0484-1 · Cited by 160
Clinicopathological features and prognosis of gastric cancer in young European adults
Santoro, R., Carboni, F., Lepiane, P., Ettorre, G. M., & Santoro, E. (2007) · British Journal of Surgery · doi:10.1002/bjs.5600 · Cited by 138
Cited by
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
Emerging trends in early-onset gastric cancer
Wang, X., Gao, X., Yu, J. M., Zhang, X., & Nie, Y. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003259 · Cited by 29
“The molecular signaling characteristics of EOGC significantly differ from those of LOGC [Table 2].”
BackgroundMethodInfluentialZhou, L., Jiang, Z., Gu, W., & Han, S. (2021) · Medicine · doi:10.1097/md.0000000000026336 · Cited by 13
“Young GC patients showed poor prognosis, which was consistent with the results of Puhr et al.[46] Their study showed that the 5year survival of patients under 45years was 17%.”
ResultLatin American young patients with gastric adenocarcinoma: worst prognosis and outcomes
Calderillo-Ruiz, G., Romero, M. D. C. D., Carbajal-López, B., Herrera-Martínez, M., Ruíz‐García, E., León-Takahashi, A. M., López-Basave, H. N., Meneses-García, A., & Herrera‐Gómez, Á. (2023) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-23-259 · Cited by 13
“All clinical features related to a bad prognosis of OS and outcome in other studies worldwide (14,24,35).”
Rinaldi, R., Laurino, S., Salvia, R., Russi, S., Stefano, F. D., Galasso, R., Sgambato, A., Scieuzo, C., Falco, G., & Falabella, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051885 · Cited by 10
Metadata
- Authors
- Puhr, H. C., Karner, A., Taghizadeh, H., Jomrich, G., Schoppmann, S. F., Preusser, M., & Ilhan-Mutlu, A.
- Affiliations
- Comprehensive Cancer Center Vienna (AT)
- ORCID
- Venue
- Journal of Cancer Research and Clinical Oncology
- Published
- 2020-07-02
- Volume
- 146
- Issue
- 12
- Pages
- 3313-3322
- ISSN
- 0084-5353 (ISSN-L)
- 0171-5216
- 1432-1335
- PMC
- PMC11802054
- OpenAlex
- W3040537958
- Cited by
- 16
- References
- 38
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 3 · 2021: 2
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Cancer Research and Clinical Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Medizinische Universität Wien
- Topics
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
- Keywords
- young patients, elderly patients, age comparison, overall survival, metastasis, delayed diagnosis, cancer screening, clinical features
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Female, Gastrointestinal Neoplasms, Humans, Male, Middle Aged, Treatment Outcome, Disease-Free Survival, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma. https://app.cochat.ai/papers/10.1007/s00432-020-03302-x
- The paper
- Puhr, H. C., Karner, A., Taghizadeh, H., Jomrich, G., Schoppmann, S. F., Preusser, M., & Ilhan-Mutlu, A. (2020). Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-020-03302-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.